[Preventing development of resistance. High potency first-line regimen permit new therapy planning].
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors